Pharmafile Logo
Pharmafocus logo
Advanced Search

JJ

Showing 11 posts of 221 posts found.

J&J post modest second quarter increase

July 21, 2010
Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

News

J&J cited by FDA for another manufacturing facility

July 20, 2010
Manufacturing and Production J&J, JJ, manufacturing compliance

Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …

News

J&J faces FDA scrutiny for another manufacturing unit

May 27, 2010
Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance

Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …

News

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

Feature

J&J continues streamlining by cutting managers

November 11, 2009
Sales and Marketing JJ, restructure

 Johnson & Johnson has announced further restructuring that will see more than 8,000 jobs being cut.The conglomerate says that it …

News

Johnson & Johnson rides out patent attack

October 16, 2009
Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …

News

J&J buys stake in vaccines firm Crucell

September 29, 2009
Sales and Marketing Crucell, JJ, vaccines

Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …

News

Janssen-Cilag wins NICE approval for psoriasis drug Stelara

September 23, 2009
Sales and Marketing JJ, NICE, Stelara

 NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …

News

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009
Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

News

Simponi approved in Canada

April 16, 2009
Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

News

Johnson & Johnson appoints new global pharma chair

October 14, 2008
Sales and Marketing JJ

Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …

News

Latest content

GSK’s Jemperli approved in EU as treatment for endometrial cancer

December 11, 2023

Daiichi Sankyo shares results for Ezharmia as lymphoma treatment

December 11, 2023

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023